AzTrials
AzTrials

Marginal DiscolorationNCT07618013

A Two-year Study Evaluating the Surface-sealed Cervical Resin Composite Restorations in Comparison With the Non-sealed Restorations

A study testing PermaSeal™, Ultradent Products Inc., USA, OPTIGLAZE™, GC, Tokyo, Japan and Conventional finishing and polishing protocol in people with Marginal Discoloration and Color Stability, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

After finishing and polishing are completed, the tooth surface may exhibit microcracks and micro-irregularities that create a roughened surface, which may lead to plaque retention, gingival inflammation, and discoloration. Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Marginal Discoloration, Color Stability
What is being tested?
PermaSeal™, Ultradent Products Inc., USA, OPTIGLAZE™, GC, Tokyo, Japan and Conventional finishing and polishing protocol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
No sites listed yet
Study dates
Jul 2026to Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Participant Inclusion Criteria:

  • Adult patients aged 18-55 years.
  • Patients with good oral hygiene (mild to moderate plaque accumulation).
  • Patients with asymptomatic class V cavities in permanent teeth.

Teeth inclusion criteria:

  • Vital posterior teeth with class V carious cavities.
  • Moderate cavities (ICDAS 3 \& 4).
  • Free from signs and symptoms of irreversible pulpitis and pulpal necrosis.
  • Teeth with no or grade 1 mobility.

Participant Exclusion Criteria:

  • Patients who are unable to return for recall appointments.
  • Patients with poor oral hygiene.
  • Presence of abnormal oral, medical, or mental condition
  • Presence of any parafunctional habits.
  • Patients with TMJ problems.

Teeth Exclusion Criteria:

  • Periodontal disease that may affect the prognosis of the restoration or the tooth itself.
  • Fractured or visibly cracked teeth.
  • Presence of any developmental or formative defects.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Nanees Ayman Hassan Aly contact

01210974750

nanees.ayman@dentistry.cu.edu.eg

About this study

Official title: Clinical Effectiveness of Using Surface Sealants on Cervical Resin Composite Restorations in Comparison With Non-sealed Restorations: A 2-year Randomized Clinical Trial

After finishing and polishing are completed, the tooth surface may exhibit microcracks and micro-irregularities that create a roughened surface, which may lead to plaque retention, gingival inflammation, and discoloration. The surface-penetrating sealant was introduced to fill micro-irregularities by capillary action, providing a uniform, regular surface and enhancing the surface smoothness. The application of unfilled low-viscosity surface sealants aims to enhance the luster, smoothness, and color stability of esthetic restorations and decrease stain absorption. They have low viscosity that enables them to easily spread and penetrate over these finished and polished surfaces, which may affect the life of the restoration positively. Additionally, it decreases surface porosity and creates a surface that is more thoroughly cured, improving the composite's stain resistance.

This prospective, parallel-group, randomized clinical study aims to compare the clinical effectiveness of using surface sealants on cervical resin composite restorations versus non-sealed restorations. Restorations will be assessed at baseline, 6, 12, 18, and 24 months using modified USPHS criteria. The primary outcome will be assessing marginal discoloration, and the secondary outcomes will be assessing color match, secondary caries, postoperative sensitivity, surface texture, and marginal adaptation. Color stability will be assessed by VITA Easyshade®.

Being tested
PermaSeal™, Ultradent Products Inc., USA, OPTIGLAZE™, GC, Tokyo, Japan, Conventional finishing and polishing protocol

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PermaSeal™, Ultradent Products Inc., USAOther

    Unfilled resin surface sealant

  • OPTIGLAZE™, GC, Tokyo, JapanOther

    Unfilled resin surface sealant

  • Conventional finishing and polishing protocolOther

    Restorations without resin surface sealants.

Study groups in NCT07618013
Study groupRoleWhat they receive
Unfilled resin surface sealant groupExperimentalPatients with carious cervical lesions (class V) in the esthetic zone receiving resin composite restorations covered by the Unfilled resin surface sealant
Receives: Other: PermaSeal™, Ultradent Products Inc., USA
Nano-filled resin surface sealant groupExperimentalPatients with carious cervical lesions (class V) in the esthetic zone receiving resin composite restorations covered by the Nano-filled resin surface sealant
Receives: Other: OPTIGLAZE™, GC, Tokyo, Japan
Class V Restorations without resin surface sealants.Active comparatorPatients with carious cervical lesions (class V) in the esthetic zone receiving resin composite restorations not covered by the resin surface sealant
Receives: Other: Conventional finishing and polishing protocol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Marginal discoloration

    Modified USPHS criteria

    Measured: 2 years

Secondary outcomes (2)
  1. Color match, Secondary caries, Postoperative sensitivity, Surface texture , Marginal adaptation

    Modified USPHS criteria

    Measured: 2 years

  2. Color stability

    by VITA Easyshade®

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2026
  2. Study startJul 2026 (estimated)
  3. Primary completionJul 2028 (estimated)
  4. Study completionAug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07618013
Sponsor's protocol ID
Surface sealants on composite
Status last verified
May 2026
First submitted
24 May 2026
Last updated
5 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The decision regarding sharing of individual participant data (IPD) has not yet been finalized.

Publications

  • • Amin, A. H., Yaakob, M. H., Nasir, W. Z. W., & Al-Kadhim, A. H. A. (2018). Evaluation the correlation between age, gender, and the incidence of cervical lesions. Journal of Clinical Research in Dentistry, 1(1). • Attia, R. M., Sobhy, E. M., & Abd El Hameed, M. E. S. (2023). Micro-Hardness and Surface Roughness of Bulk-Fill Composite Resin: Effect of Surface Sealant Application and Two Bleaching Regimens. European Journal of General Dentistry, 12(03), 169-176. • Calazans, F. S., Ferreira, T. D. M. J., Ñaupari-Villasante, R., Mendonça, R. P., Ornellas, G., Albuquerque, E. G., ... & Loguercio, A. D. (2024). Influence of surface sealants on the quality of posterior restorations with bulk-fill composites: A 4-year randomized clinical trial. Dental Materials, 40(3), 466-476. • Dawoud, B., Abou-Auf, E., & Shaalan, O. (2025). 24-Month clinical evaluation of cervical restorations bonded using radio-opaque universal adhesive compared to conventional universal adhesive in carious cervical lesions: A randomized clinical trial. Scientific Reports, 15(1), 5505. • Demarco, F. F., Collares, K., Coelho-de-Souza, F. H., Correa, M. B., Cenci, M. S., Moraes, R. R., & Opdam, N. J. (2015). Anterior composite restorations: A systematic review on long-term survival and reasons for failure. Dental materials, 31(10), 1214-1224. • de Melo Soares, V., de Oliveira Bomfim, H. L. Q., Romão, D. A., de Moraes Porto, I. C. C., & de Mendonça Fragoso, L. S. (2024). Comparative Analysis of Different Methods of Marginal Microleakage Evaluation for Restored Teeth by Composite Resin. Journal of Health Sciences, 26(4), 221-225. • Elwassefy, N., ElEmbaby, A., & Elkholany, N. (2023). Correlation between surface roughness and color stability of nano-and micro-hybrid resin composites using different surface treatment protocols. Egyptian Dental Journal, 69(1), 705-713.

Questions about this trial

What is this clinical trial studying?

A study testing PermaSeal™, Ultradent Products Inc., USA, OPTIGLAZE™, GC, Tokyo, Japan and Conventional finishing and polishing protocol in people with Marginal Discoloration and Color Stability, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nanees Ayman Hassan Aly (01210974750, nanees.ayman@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Marginal discoloration (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07618013, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2026; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in